Transcriptional modulation of hepatocyte nuclear factor 4a (HNF-4a) and/or peroxisome proliferator-activated receptor a (PPARa)-controlled genes by low molecular weight compounds

Author： Bar-Tana J.  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.2, Iss.1, 1998-07, pp. : 141-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transcriptional Regulation of Cytochrome P450 Genes by the Nuclear Receptor Hepatocyte Nuclear Factor 4-Alpha

By  

Current Drug Metabolism, Vol. 10, Iss. 5, 2009-06 ,pp. : 508-519

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor ligands in atherosclerosis

By Viles-Gonzalez Juan F   Choi Brian G   Fuster Valentin   Badimon Juan J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1393-1403

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Peroxisome Proliferator-Activated Receptor Science

By  

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 267-280

Bentham Science Publishers

Access to resources Recommend Favorite

Modulation of Microglial Innate Immunity in Alzheimer's Disease by Activation of Peroxisome Proliferator-activated Receptor Gamma

By  

Current Medicinal Chemistry, Vol. 16, Iss. 6, 2009-02 ,pp. : 643-651

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)-α: A Pharmacological Target with a Promising Future

By van Raalte Daniel H.   Li Min   Pritchard P. Haydn   Wasan Kishor M.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1531-1538

Springer Publishing Company

Access to resources Recommend Favorite